misonidazole has been researched along with Fibrosarcoma in 44 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 31 (70.45) | 18.7374 |
1990's | 7 (15.91) | 18.2507 |
2000's | 4 (9.09) | 29.6817 |
2010's | 2 (4.55) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banerjee, S; Mallia, MB; Mathur, A; Sarma, HD | 1 |
Azzouz, R; Bailly, L; Bischoff, L; Bohn, P; Deyine, A; Fiol-Petit, C; Fruit, C; Marsais, F; Vera, P | 1 |
Korde, A; Krishnamurthy, NV; Nandy, S; Rajan, MG | 1 |
Ballinger, JR; Hsue, V; Rauth, AM | 1 |
Cai, S; Chapman, JD; Chen, Y; Finn, R; Gerweck, L; Humm, J; Larson, S; Ling, C; O'Donoghue, J; Ruan, S; Schneider, R; Wen, B; Zanzonico, P | 1 |
Denekamp, J; Rojas, A; Williams, MV | 1 |
Hinchliffe, M; McNally, NJ | 1 |
Denekamp, J; Rojas, A; Stewart, FA | 1 |
Hunter, N; Ito, H; Milas, L | 1 |
Denekamp, J; Rojas, A | 1 |
Meyn, RE; Murray, D | 4 |
Okada, S; Sakamoto, K; Takada, C; Takahashi, M; Yasunaga, T | 1 |
Grdina, DJ; Milas, L; Thames, HD | 1 |
Baer, K; Chapman, JD; Lee, J | 1 |
Dembs, N; Mulcahy, RT | 1 |
Creasey, WA; Thrall, DE | 1 |
Chapman, JD; Franko, AJ; Sharplin, J | 1 |
De Ronde, J; Martin, WM; McNally, NJ | 1 |
Grdina, DJ; Jovonovich, JA; Sigdestad, CP | 1 |
Tannock, IF | 2 |
Dachs, GU; Firth, JD; Harris, AL; Patterson, AV; Ratcliffe, PJ; Stratford, IJ; Townsend, KM | 1 |
Chin, LK; Hofstrand, PD; Rasey, JS; Tewson, TJ | 1 |
Airley, R; Cowen, RL; Honess, D; Jaffar, M; Patterson, AV; Saunders, M; Stratford, IJ; Telfer, BA; van der Kogel, AJ; Williams, KJ; Wolf, CR | 1 |
Bleehen, NM; Owen, LN; White, RA; Workman, P | 1 |
Arundel-Suto, CM; Elliott, WE; Leopold, WR; Sebolt-Leopold, JS; Stier, MA; Suto, MJ; Werbel, LM | 1 |
Herman, TS; Holden, SA; Rudolph, MB; Teicher, BA | 1 |
Herman, TS; Holden, SA; Teicher, BA | 1 |
Herman, TS; Holden, SA; Jones, SM; Pfeffer, MR; Teicher, BA | 1 |
Chapnick, RM; Herman, TS; Kalick, GS; Khandekar, V; Pfeffer, MR; Rabow, A; Teicher, BA | 1 |
Herman, TS; Holden, SA; Jones, SM; Teicher, BA | 1 |
Herman, TS; Kaufmann, M; Teicher, BA | 1 |
Evelhoch, JL; Giri, BP; McCoy, CL | 1 |
Hodgkiss, RJ; Stratford, MR | 1 |
Walton, MI; Workman, P | 1 |
Epp, ER; Hsieh, CC; Ngo, FQ; Roberts, WK; Sedlacek, R; Silver, G; Suit, HD; Verhey, L | 1 |
Okunieff, P; Suit, HD | 1 |
Milas, L; Stone, HB | 1 |
de Ronde, J; Hinchliffe, M; McNally, NJ; Minchinton, AI | 1 |
Lee, FY; Workman, P | 1 |
Denekamp, J; Randhawa, VS; Stewart, FA; Stratford, MR | 1 |
44 other study(ies) available for misonidazole and Fibrosarcoma
Article | Year |
---|---|
A (99m)Tc-labeled misonidazole analogue: step toward a (99m)Tc-alternative to [18F]fluromisonidazole for detecting tumor hypoxia.
Topics: Animals; Fibrosarcoma; Hypoxia; Mice; Misonidazole; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2015 |
Design of silicon-based misonidazole analogues and (18)F-radiolabelling.
Topics: Animals; Cell Line, Tumor; Fibrosarcoma; Fluorine Radioisotopes; Isotope Labeling; Male; Metabolic Clearance Rate; Mice; Mice, Inbred C3H; Misonidazole; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Silicon; Tissue Distribution | 2009 |
The possibility of a fully automated procedure for radiosynthesis of fluorine-18-labeled fluoromisonidazole using a simplified single, neutral alumina column purification procedure.
Topics: Aluminum Oxide; Animals; Automation; Chromatography; Fibrosarcoma; Fluorine Radioisotopes; Humans; Misonidazole; Positron-Emission Tomography; Rabbits; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tissue Distribution | 2010 |
Accumulation of technetium-99m glucarate: in vitro cell cultures and in vivo tumour models.
Topics: Animals; Azides; Carcinoma, Squamous Cell; CHO Cells; Cricetinae; Cricetulus; Fibrosarcoma; Fructose; Glucaric Acid; Hypoxia; Male; Metabolic Clearance Rate; Metronidazole; Mice; Mice, Inbred C3H; Misonidazole; Organotechnetium Compounds; Oxygen; Potassium Cyanide; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2003 |
Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.
Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Female; Fibrosarcoma; Mammary Neoplasms, Animal; Metabolic Clearance Rate; Mice; Mice, Inbred C3H; Misonidazole; Monosaccharides; Nitroimidazoles; Organ Specificity; Tissue Distribution; Tomography, Emission-Computed | 2004 |
Tumor sensitization and protection: influence of stromal injury on estimates of dose modification.
Topics: Amifostine; Animals; Dose-Response Relationship, Radiation; Fibrosarcoma; Mice; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Radiation-Protective Agents; Radiation-Sensitizing Agents | 1984 |
A comparison of the ability of some radiosensitizers undergoing clinical trials to act as chemosensitizers.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Etanidazole; Fibrosarcoma; Melphalan; Mice; Mice, Inbred CBA; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents | 1984 |
Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
Topics: Amifostine; Animals; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Fibrosarcoma; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Organothiophosphorus Compounds; Radiation Tolerance; Sarcoma, Experimental | 1983 |
Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
Topics: Amifostine; Animals; Cyclophosphamide; Drug Interactions; Drug Therapy, Combination; Extremities; Female; Fibrosarcoma; Lung Neoplasms; Male; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Organothiophosphorus Compounds; Time Factors | 1983 |
Time dependence of interaction of misonidazole and WR-2721.
Topics: Amifostine; Animals; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Interactions; Fibrosarcoma; Mice; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Organothiophosphorus Compounds; Sarcoma, Experimental; Time Factors | 1983 |
Effect of misonidazole pretreatment on nitrogen mustard-induced DNA cross-linking in mouse tissues in vivo.
Topics: Animals; Cross-Linking Reagents; DNA; Drug Synergism; Fibrosarcoma; Jejunum; Kidney; Liver; Mechlorethamine; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Spleen | 1984 |
[Effect of even or uneven dose fractionation regime on murine squamous cell carcinoma with combined use of misonidazole].
Topics: Animals; Carcinoma, Squamous Cell; Combined Modality Therapy; Fibrosarcoma; Mice; Mice, Inbred Strains; Misonidazole; Nitroimidazoles; Radiotherapy Dosage | 1983 |
Enhancement of the DNA cross-linking activity of nitrogen mustard by misonidazole and diethyl maleate in a mouse fibrosarcoma tumor in vivo.
Topics: Animals; DNA, Neoplasm; Drug Administration Schedule; Fibrosarcoma; Kinetics; Maleates; Mechlorethamine; Mice; Mice, Inbred Strains; Misonidazole; Nitroimidazoles | 1984 |
Tumor sensitizing effect by misonidazole in a clinically relevant radiation dose range.
Topics: Animals; Cell Survival; Cells, Cultured; Dose-Response Relationship, Radiation; Female; Fibrosarcoma; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation Tolerance; Sarcoma, Experimental; Tumor Stem Cell Assay | 1984 |
Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo.
Topics: Animals; Cross-Linking Reagents; DNA; DNA Repair; DNA, Neoplasm; Fibrosarcoma; Glutathione; Jejunum; Maleates; Melphalan; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental; Spleen | 1983 |
Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells.
Topics: Anaerobiosis; Animals; Binding, Competitive; Cell Line; Cricetinae; Cricetulus; Fibrosarcoma; Kidney; Kinetics; Mice; Misonidazole; Nitroimidazoles; Sarcoma, Experimental; Temperature | 1983 |
Time-dose relationships for simultaneous misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea exposures in vitro.
Topics: Animals; Carmustine; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Fibrosarcoma; Mice; Misonidazole; Nitroimidazoles; Time Factors | 1983 |
Pharmacokinetic and anti-tumor studies with the radiosensitizer misonidazole in dogs with spontaneous fibrosarcomas.
Topics: Animals; Dog Diseases; Dogs; Fibrosarcoma; Mandibular Neoplasms; Maxillary Neoplasms; Misonidazole; Mouth Neoplasms; Nitroimidazoles; Palate, Soft | 1982 |
A marker for hypoxic cells in tumours with potential clinical applicability.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Cells, Cultured; Cricetinae; Fibrosarcoma; Mice; Mice, Inbred BALB C; Misonidazole; Oxygen Consumption; Sarcoma, Experimental | 1981 |
Enhancement of the effect of cytotoxic drugs by radiosensitizers.
Topics: Animals; Cell Survival; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Fibrosarcoma; In Vitro Techniques; Melphalan; Mice; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental; Urination | 1981 |
The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations.
Topics: Animals; Cell Survival; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Fibrosarcoma; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1980 |
In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin.
Topics: Animals; Body Weight; Doxorubicin; Drug Therapy, Combination; Fibrosarcoma; Fluorouracil; Leukocyte Count; Male; Mammary Neoplasms, Experimental; Methotrexate; Metronidazole; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1980 |
In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
Topics: Animals; Body Weight; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Fibrosarcoma; Leukocyte Count; Male; Mammary Neoplasms, Experimental; Metronidazole; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1980 |
Targeting gene expression to hypoxic tumor cells.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Hypoxia; Cytosine Deaminase; DNA-Binding Proteins; Fibrosarcoma; Flucytosine; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Nuclear Proteins; Nucleoside Deaminases; Oxygen; Phosphoglycerate Kinase; Prodrugs; Promoter Regions, Genetic; Recombinant Fusion Proteins; Transcription Factors; Tumor Cells, Cultured | 1997 |
Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia.
Topics: Animals; Binding Sites; Blood-Brain Barrier; Cell Hypoxia; Chromatography, High Pressure Liquid; Contrast Media; Cricetinae; Cricetulus; Etanidazole; Female; Fibroblasts; Fibrosarcoma; Fluorine Radioisotopes; Glioma; Lung; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Oxygen; Radionuclide Imaging; Radiopharmaceuticals; Rats; Sarcoma, Experimental; Time Factors; Tissue Distribution; Tumor Cells, Cultured | 1999 |
Oxygen-sensitive enzyme-prodrug gene therapy for the eradication of radiation-resistant solid tumours.
Topics: Animals; Combined Modality Therapy; Female; Fibrosarcoma; Genetic Therapy; Genetic Vectors; Humans; Hypoxia; Mice; Mice, Nude; Misonidazole; NADPH-Ferrihemoprotein Reductase; Neoplasm Transplantation; Nitroimidazoles; Prodrugs; Radiation Tolerance; Radiation-Sensitizing Agents; Transplantation, Heterologous; Tumor Cells, Cultured | 2002 |
The penetration of misonidazole into spontaneous canine tumours.
Topics: Adenocarcinoma; Anesthesia, Intravenous; Animals; Carcinoma, Squamous Cell; Disease Models, Animal; Dog Diseases; Dogs; Female; Fibrosarcoma; Half-Life; Lymphoma, Non-Hodgkin; Male; Mammary Glands, Animal; Meningioma; Misonidazole; Neoplasms; Nitroimidazoles; Osteosarcoma; Pentobarbital | 1979 |
A new class of analogues of the bifunctional radiosensitizer alpha-(1-aziridinylmethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069): the cycloalkylaziridines.
Topics: Animals; Aziridines; Cell Line; Cell Survival; Chemical Phenomena; Chemistry; Cricetinae; Fibrosarcoma; Mice; Misonidazole; Molecular Structure; Nitroimidazoles; Oxygen; Pyrans; Radiation-Sensitizing Agents; Structure-Activity Relationship | 1991 |
Effect of oxygenation, pH and hyperthermia on RSU-1069 in vitro and in vivo with radiation in the FSaIIC murine fibrosarcoma.
Topics: Animals; Benzimidazoles; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Radiation; Fibrosarcoma; Fluorescent Dyes; Hydrogen-Ion Concentration; Hyperthermia, Induced; Male; Mice; Mice, Inbred C3H; Misonidazole; Oxygen; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1991 |
Effect of environmental conditions (pH, oxygenation, and temperature) on misonidazole cytotoxicity and radiosensitization in vitro and in vivo in FSaIIC fibrosarcoma.
Topics: Animals; Antineoplastic Agents; Cell Survival; Combined Modality Therapy; Fibrosarcoma; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Oxygen; Radiation-Sensitizing Agents; Temperature | 1991 |
Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma.
Topics: Animals; Cell Survival; Cisplatin; Combined Modality Therapy; Drug Therapy, Combination; Etanidazole; Fibrosarcoma; Hyperthermia, Induced; Male; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1990 |
Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II).
Topics: Animals; Cell Line; Cell Survival; Cisplatin; Etanidazole; Fibrosarcoma; Hydrogen-Ion Concentration; In Vitro Techniques; Mice; Misonidazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1990 |
Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
Topics: Animals; Carbon Dioxide; Combined Modality Therapy; Drug Combinations; Etanidazole; Fibrosarcoma; Fluorocarbons; Hydroxyethyl Starch Derivatives; Hyperthermia, Induced; Male; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1989 |
Platinum complexes of triaminotriphenylmethanes: interaction with DNA and radiosensitization.
Topics: Animals; Cell Hypoxia; Cell Survival; DNA; Dose-Response Relationship, Drug; Fibrosarcoma; Male; Methyl Green; Mice; Mice, Inbred C3H; Misonidazole; Molecular Conformation; Neoplasm Transplantation; Organoplatinum Compounds; Radiation-Sensitizing Agents; Rosaniline Dyes; Sarcoma, Experimental; Tumor Cells, Cultured | 1989 |
A method for direct in vivo measurement of drug concentrations from a single 2H NMR spectrum.
Topics: Animals; Deuterium; Evaluation Studies as Topic; Female; Fibrosarcoma; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C3H; Misonidazole; Pharmaceutical Preparations; Water | 1989 |
Competitive dose-modification between ascorbate and misonidazole in human and hamster cells: effects of glutathione depletion.
Topics: Animals; Ascorbic Acid; Cell Line; Cell Survival; Cricetinae; Fibrosarcoma; Glutathione; Humans; Misonidazole; Radiation Tolerance; Tumor Cells, Cultured | 1988 |
Pharmacokinetics and metabolism of the mixed-function hypoxic cell sensitizer prototype RSU 1069 in mice.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Chromatography, High Pressure Liquid; Female; Fibrosarcoma; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Radiation-Sensitizing Agents | 1988 |
Therapeutic gain factors for fractionated radiation treatment of spontaneous murine tumors using fast neutrons, photons plus O2(1) or 3 ATA, or photons plus misonidazole.
Topics: Animals; Carcinoma, Squamous Cell; Combined Modality Therapy; Fast Neutrons; Female; Fibrosarcoma; Hyperbaric Oxygenation; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Oxygen; Radiotherapy Dosage | 1988 |
Toxicity, radiation sensitivity modification, and combined drug effects of ascorbic acid with misonidazole in vivo on FSaII murine fibrosarcomas.
Topics: Animals; Ascorbic Acid; Bone Marrow; Cell Division; Drug Interactions; Female; Fibrosarcoma; Male; Mice; Mice, Inbred C3H; Misonidazole; Radiation Tolerance; Radiation-Protective Agents; Skin | 1987 |
Enhancement of radiation-induced normal tissue damage by a fibrosarcoma.
Topics: Animals; Contracture; Dose-Response Relationship, Radiation; Female; Fibrosarcoma; Leg; Mice; Mice, Inbred C3H; Misonidazole; Muscular Diseases; Radiation Dosage; Radiation Injuries, Experimental; Time Factors | 1987 |
The relationship between the misonidazole "pre-incubation" effect and misonidazole-induced depletion of cellular GSH.
Topics: Animals; Cell Survival; Fibrosarcoma; Glutathione; In Vitro Techniques; Mice; Misonidazole; Oxygen | 1987 |
Misonidazole protects mouse tumour and normal tissues from the toxicity of oral CCNU.
Topics: Administration, Oral; Animals; Drug Interactions; Fibrosarcoma; Injections, Intraperitoneal; Lethal Dose 50; Lomustine; Male; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles | 1985 |
Factors influencing the chemosensitization of melphalan by misonidazole.
Topics: Animals; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrosarcoma; Kinetics; Melphalan; Mice; Mice, Inbred Strains; Misonidazole; Nitroimidazoles; Temperature | 1985 |
DNA damage in normal and neoplastic mouse tissues after treatment with misonidazole in vivo.
Topics: Animals; Cell Line; DNA; DNA, Neoplasm; Dose-Response Relationship, Drug; Fibrosarcoma; Hydrogen-Ion Concentration; Kidney; Kinetics; Liver; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Organ Specificity | 1985 |